University of Oxford researchers today report the results of vaccinated people who are most at risk of severe MERS-CoV infection leading to hospitalization or death 14 days after second-dose ARV vaccination where significant immunity should be expected..
According to the university’s statement on its official website, these categories are those with weakened immunity as a result of chemotherapy, bone marrow or solid organ transplants, HIV / AIDS, people with neurological disorders, including dementia and Parkinson’s disease, and those with chronic disorders. Including Down syndrome.
In a research paper published in the British Medical Journal, they wrote that by updating the QCovid Developed in 2020, which directly influenced UK policy in February 2021 by adding 1.5 million people in February 2021 to the list of those advised to protect, they are able to identify groups most at risk of hospitalization or death from COVID-19..
Accordingly, the researchers developed cumulative risk scores to calculate the risk of people being hospitalized or dying from corona after one or two doses of vaccination. regarding the following:
- Those with immunosuppression as a result of chemotherapy, bone marrow or solid organ transplantation, or HIV/AIDS
- People with neurological disorders, including dementia and Parkinson’s disease
- and those with chronic disorders, including Down syndrome
This massive national study of more than 5 million people vaccinated with two doses across the UK found that a small minority of people remain at risk of hospitalization and death Our risk calculator helps determine those who remain at greatest risk after vaccination.
tool is designed QCovid Our new product, which was developed with the help of experts from across the UK, to identify high-risk people who may benefit from interventions such as booster vaccine doses or new treatments such as monoclonal antibodies, which can help reduce the risk of developing COVID-19 infection into Serious consequences of the virus.